Found: 13
Select item for more details and to access through your institution.
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. 628, doi. 10.1111/bjh.18690
- By:
- Publication type:
- Article
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
- Published in:
- 2013
- By:
- Publication type:
- journal article
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened 'GO question'.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1309, doi. 10.1007/s00277-013-1780-7
- By:
- Publication type:
- Article
OAB-004: Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S3, doi. 10.1016/S2152-2650(21)02078-4
- By:
- Publication type:
- Article
Non-thrombotic pulmonary embolism of brain, liver, or bone marrow tissues associated with traumatic injuries in free-ranging neotropical primates.
- Published in:
- Veterinary Pathology, 2022, v. 59, n. 3, p. 482, doi. 10.1177/03009858221075595
- By:
- Publication type:
- Article
Histopathologic Patterns and Susceptibility of Neotropical Primates Naturally Infected With Yellow Fever Virus.
- Published in:
- Veterinary Pathology, 2020, v. 57, n. 5, p. 681, doi. 10.1177/0300985820941271
- By:
- Publication type:
- Article
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin’s lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 9, p. 855, doi. 10.1007/s00277-009-0699-5
- By:
- Publication type:
- Article
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD + -Lowering Agents.
- Published in:
- Antioxidants, 2023, v. 12, n. 2, p. 494, doi. 10.3390/antiox12020494
- By:
- Publication type:
- Article
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Haploidentical bone marrow transplantation in patients with advanced myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E117, doi. 10.1002/ajh.24725
- By:
- Publication type:
- Article
Radiomics and Artificial Intelligence for Outcome Prediction in Multiple Myeloma Patients Undergoing Autologous Transplantation: A Feasibility Study with CT Data.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 10, p. 1759, doi. 10.3390/diagnostics11101759
- By:
- Publication type:
- Article
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 18, p. 3413, doi. 10.1002/cncr.33647
- By:
- Publication type:
- Article
Pathology and epidemiology of fatal toxoplasmosis in free-ranging marmosets (Callithrix spp.) from the Brazilian atlantic forest.
- Published in:
- PLoS Neglected Tropical Diseases, 2022, v. 16, n. 9, p. 1, doi. 10.1371/journal.pntd.0010782
- By:
- Publication type:
- Article